A Study to Learn More About The Safety of Diroximel Fumarate (VUMERITY®) in Participants Who Took it During Pregnancy And About the Health of Their Babies
Public ClinicalTrials.gov record NCT05688436. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Pregnancy Outcomes in Women Exposed to Diroximel Fumarate
Study identification
- NCT ID
- NCT05688436
- Recruitment status
- Active, not recruiting
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Biogen
- Industry
- Enrollment
- 1,178 participants
Conditions and interventions
Conditions
Interventions
- Diroximel Fumarate Drug
- Alemtuzumab Biological
- Fingolimod Drug
- Glatiramer acetate Drug
- Interferon beta Biological
- Natalizumab Biological
- Ocrelizumab Biological
- Ofatumumab Biological
- Ozanimod Drug
- Peginterferon beta-1a Biological
- Ponesimod Drug
- Siponimod Drug
Drug · Biological
Eligibility (public fields only)
- Age range
- 18 Years to 49 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 23, 2021
- Primary completion
- Jan 16, 2031
- Completion
- Jan 16, 2031
- Last update posted
- Jun 3, 2026
2021 – 2031
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| OptumInsight | Eden Prairie | Minnesota | 55344-2503 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05688436, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 3, 2026 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05688436 live on ClinicalTrials.gov.